Hastings Laboratory Grants
AZ-Discovery Boost Grant, 2024-2025 (Hastings, PI)
American Cancer Society
T cell sculpting of the neoantigen landscape in cutaneous squamous cell carcinoma
I01BX005336, 2021-2025 (Hastings, PI)
Department of Veterans Affairs
MHC class II antigen presentation in melanoma: impact on immune recognition
Supplement (2022-2024)
Training Grants and Fellowships
F30CA281056 (Borden, PI), 2023-2027
NIH/NCI
Immunoediting in cutaneous squamous cell carcinoma
Role: Sponsor for MDPhD student Elizabeth Borden
F30CA257622 (Adams, PI), 2023-2026
NIH/NCI
Neoantigen-specific T cells in a novel cutaneous squamous cell carcinoma model
Role: Sponsor for MDPhD student Anngela Adams
R25CA221777 (Godfrey and Solheim, MPI), 2017-2023
NIH/NCI
Ignite-Engage-Sustain: a comprehensive approach to motivate, involve, educate, and mentor Native American students and their communities in cancer prevention, treatment, and research.
Role: Consortium PI
Collaborative Grants
R21AG083558 (Migrino, PI), 2023-2025
NIH/NIA
Anti-medin immunotherapy for vascular aging and related dementias
Role: Co-I
R01HL153112 (Hale, PI), 2022-2025
NIH/NHLBI
Targeting resident cardiac fibroblast subpopulations for protection against fibrosis
Role: Co-I to provide flow cytometry
P01CA229112 (Curiel-Lewandrowski and Wondrak, MPI), 2019-2024
NIH/NCI
Targeted Prevention for Non-Melanoma Skin Cancer
Role: Co-I
Completed Hastings laboratory grants
UG1CA242596 (Chow and Bauman, MPI), 2019-2024
NIH/NCI
University of Arizona Cancer Prevention Clinical Trials Network
Biomarker development for early phase clinical trials for melanoma prevention
Role: PI, Rapid Response Restricted Funds Proposal, 2020-2022
Collaborative research agreement (Hastings, PI), 2012-2023
Ventana Medical Systems (Tucson, AZ)
Ventana provides reagents, immunohistochemical staining of human melanocytic lesions and lymphoma tissue, equipment lease and training with no payment to either Ventana or academic investigator.
Basic Science Award (Hastings, PI), 2020-2022
Harry J Lloyd Charitable Trust
MHC class II presentation in melanoma: impact on immune recognition
R03AR063259-01A1, 2013-2017 (Hastings, PI), 2013-2017
NIH/NIAMS
GILT and regulation of Treg development in cutaneous autoimmunity
Arizona Biomedical Research Commission (Hastings, PI), 2011-2014
Regulation of immune tolerance to melanoma
K08AR053288 (Hastings, PI), 2007-2013
NIH/NIAMS
MHC class II antigen processing and immune recognition of melanoma
Career Development Research Award (Hastings, PI), 2008-2009
Melanoma Research Foundation
Role of lysosomal thiol reductase GILT in activation of melanoma-specific T lymphocytes
Dermatology Investigator Research Fellowship (Hastings, PI), 2005-2006
Dermatology Foundation
Role of GILT in MHC class II processing and presentation
Role: PI
Completed training grants and fellowships
T32CA009213 (Cress, Rogers, Curiel-Lewandrowski, MPI), 2022-2024
NIH/NCI
Integrative Cancer Scholars Training Grant
Role: Mentor for MD/PhD student, Anngela Adams
Training Oncology Physician Scientists (Borden, PI), 2022-2023
University of Arizona Cancer Center
Cancer neoantigen predictions and prioritization
Role: Mentor for MD/PhD student, Elizabeth Borden
Medical Student Grant Targeting Melanoma and Skin Cancer (Adams, PI), 2022-2023
American Skin Association
Novel cutaneous squamous cell carcinoma model to investigate tumor-specific T cell responses
Role: Mentor for MD/PhD student, Anngela Adams
Medical Student Award (Borden, PI), 2021-2022
Melanoma Research Foundation
Evolution of the neoantigen landscape through melanoma progression
Role: Mentor for MD/PhD student, Elizabeth Borden
Graduate Medical Trainee and Graduate Student Cornerstone Grant (Adams, PI), 2020-2021
Histochemical Society
Association of gamma-interferon-inducible thiol reductase (GILT) with clinical outcomes in patients with metastatic melanoma
Role: Mentor for MD/PhD student, Anngela Adams
T32CA009213 (Martinez, PI), 2016-2018
NIH/NCI
Cancer Biology Training Grant
Role: Mentor for postdoctoral trainee, Lydia Meador, PhD (2016-2018)
Young Investigator Award (Rausch, PI), 2013-2014
Adaptive Biotechnologies
Effect of GILT expression in antigen presenting cells on the T cell repertoire that responds to melanoma
Role: Mentor for postdoctoral trainee, Matthew Rausch, PhD
T32CA009213 (Martinez, PI), 2010-2013
NIH/NCI
Cancer Biology Training Grant
Role: Mentor for postdoctoral trainee, Hannah Phipps-Yonas, PhD
T32CA009213 (Bowden, PI), 2009-2011
NIH/NCI
Cancer Biology Training Grant
Role: Mentor for postdoctoral trainee, Matthew Rausch, PhD
Completed collaborative grants
P30CA023074 (Sweasy, PI), 1997-2021
NIH/NCI
University of Arizona Cancer Center – Cancer Center Support Grant
Role: Gunatilaka and Hastings, MPI, Basic/Clinical Partnerships to Promote Translational Research – Immune mechanisms of a novel melanoma therapy invented at UA (2020-2021)
ADHS-16-162515 Investigator Grant (Gunatilaka, PI), 2017-2021
Arizona Biomedical Research Centre
Natural product-based induction of cancer cell death combined with immunotherapy for melanoma treatment
R25CA078447 (Alberts, PI), 2006-2007
NIH/NCI
Cancer Prevention and Control Training Grant
T32AR007016 (Edelson, PI), 2003-2006
NIH/NIAMS
Research Training in Dermatology
Role: Postdoctoral researcher
P30AR041942 (Tigelaar, PI), 2004-2005
NIH/NIAMS
Yale Skin Disease Research Core Center
Role: Pilot Feasibility Award, GILT in the immune response to melanoma, Peter Cresswell, mentor